Adcentrx gets FDA clearance for phase 1 trial of ADC for tumors

Adcentrx gets FDA clearance for phase 1 trial of ADC for tumors

Submitted by admin on October 22, 2024 - 11:31am
Source: 
Biopharma Reporter
News Tags: 
Adcentrx
solid tumors
clinical trials
FDA
ADRX-0405
Headline: 
Adcentrx gets FDA clearance for phase 1 trial of ADC for tumors
snippet: 

The FDA has given clearance to Adcentrx Therapeutics' IND application for an antibody-drug conjugate (ADC) targeting solid tumors.

Do Not Allow Advertisers to Use My Personal information